BACKGROUND: Granzyme B (GrB) is recognized to induce apoptosis; however, little is known about its possible role in other biological events. IL-18, a potent inflammatory cytokine, is produced as an inactive precursor (proIL-18). Several cells, including monocytes/macrophage lineage and non-hematopoietic cells such as keratinocytes, produce proIL-18. ProIL-18 requires appropriate processing to become active. Caspase-1 is the authentic IL-18 processing enzyme and is essential for IL-18 release from monocyte/macrophage lineage cells. However, caspase-1 is absent in non-hematopoietic cells, suggesting that there is another candidate to cleave proIL-18 except for caspase-1. OBJECTIVE: GrB can invade and be active in cytoplasm of non-hematopoietic cells via perforin, therefore we investigated whether GrB converts proIL-18 into the biologically active form. METHODS: Recombinant proIL-18 (rproIL-18) was produced and purified for protease reaction with GrB; this incubate was evaluated by immunoblotting. Biological activity of the proteolytic fragment cleaved by GrB was determined by IFN-gamma assay using KG-1 cells. IFN-gamma induction was also analyzed between extracts from GrB(+)/caspase-1(-) human CD8+ T cells and proIL-18 from normal human keratinocytes (NHK). RESULTS: The proteolytic fragment that GrB cleaved proIL-18 had the same sequence and biological activity compared with mature IL-18 cleaved by caspase-1. Culture extracts from CD8+ T cells was able to cleave proIL-18 into authentic mature IL-18. IFN-gamma induction was also detected in NHK treated with CD8+ T cells. CONCLUSION: GrB is a potent IL-18 converting enzyme and suggest that GrB secreted by CTLs and/or NK cells may initiate IL-18 release from target cells, leading to the development of inflammation. Copyright 2010 Japanese Society for Investigative Dermatology. All rights reserved.
BACKGROUND:Granzyme B (GrB) is recognized to induce apoptosis; however, little is known about its possible role in other biological events. IL-18, a potent inflammatory cytokine, is produced as an inactive precursor (proIL-18). Several cells, including monocytes/macrophage lineage and non-hematopoietic cells such as keratinocytes, produce proIL-18. ProIL-18 requires appropriate processing to become active. Caspase-1 is the authentic IL-18 processing enzyme and is essential for IL-18 release from monocyte/macrophage lineage cells. However, caspase-1 is absent in non-hematopoietic cells, suggesting that there is another candidate to cleave proIL-18 except for caspase-1. OBJECTIVE:GrB can invade and be active in cytoplasm of non-hematopoietic cells via perforin, therefore we investigated whether GrB converts proIL-18 into the biologically active form. METHODS: Recombinant proIL-18 (rproIL-18) was produced and purified for protease reaction with GrB; this incubate was evaluated by immunoblotting. Biological activity of the proteolytic fragment cleaved by GrB was determined by IFN-gamma assay using KG-1 cells. IFN-gamma induction was also analyzed between extracts from GrB(+)/caspase-1(-) human CD8+ T cells and proIL-18 from normal human keratinocytes (NHK). RESULTS: The proteolytic fragment that GrB cleaved proIL-18 had the same sequence and biological activity compared with mature IL-18 cleaved by caspase-1. Culture extracts from CD8+ T cells was able to cleave proIL-18 into authentic mature IL-18. IFN-gamma induction was also detected in NHK treated with CD8+ T cells. CONCLUSION:GrB is a potent IL-18 converting enzyme and suggest that GrB secreted by CTLs and/or NK cells may initiate IL-18 release from target cells, leading to the development of inflammation. Copyright 2010 Japanese Society for Investigative Dermatology. All rights reserved.
Authors: Saranya Elavazhagan; Kavin Fatehchand; Vikram Santhanam; Huiqing Fang; Li Ren; Shalini Gautam; Brenda Reader; Xiaokui Mo; Carolyn Cheney; Edward Briercheck; John P Vasilakos; Gregory N Dietsch; Robert M Hershberg; Michael Caligiuri; John C Byrd; Jonathan P Butchar; Susheela Tridandapani Journal: J Immunol Date: 2015-02-09 Impact factor: 5.422
Authors: Abigail Jarret; Ruaidhrí Jackson; Coco Duizer; Marc E Healy; Jun Zhao; Joseph M Rone; Piotr Bielecki; Esen Sefik; Manolis Roulis; Tyler Rice; Kisha N Sivanathan; Ting Zhou; Angel G Solis; Hanna Honcharova-Biletska; Karelia Vélez; Saskia Hartner; Jun Siong Low; Rihao Qu; Marcel R de Zoete; Noah W Palm; Aaron M Ring; Achim Weber; Andreas E Moor; Yuval Kluger; Roni Nowarski; Richard A Flavell Journal: Cell Date: 2020-01-09 Impact factor: 41.582
Authors: Yuanyue Zhang; Ivan Ting Hin Fung; Poornima Sankar; Xiangyu Chen; Lisa S Robison; Longyun Ye; Shanti S D'Souza; Abigail E Salinero; Marcy L Kuentzel; Sridar V Chittur; Wenzheng Zhang; Kristen L Zuloaga; Qi Yang Journal: J Immunol Date: 2020-06-05 Impact factor: 5.422
Authors: Laura C O'Brien; Eleonora Mezzaroma; Benjamin W Van Tassell; Carlo Marchetti; Salvatore Carbone; Antonio Abbate; Stefano Toldo Journal: Mol Med Date: 2014-06-12 Impact factor: 6.354